Stanford stem cell luminary Irv Weissman is building a new biotech around the ‘don’t eat me’ signal CD47 — but instead of cancer, the new biotech is developing anti-CD47 therapies for heart disease.
Nicholas Leeper Bitterroot Bio, named after the Bitterroot river in Weissman’s...
